Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis-Reference-Cited by-全球学者库

Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis

Published:2022-01-17 Issue: Volume: Page:
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transplantation

Author:

Yan Xiangyu¹²,Huang Songhan¹²,Yang Yang¹²,Lu Ziwen¹²,Li Feiyu¹²,Jiang Liyong¹²,Jiang Yong¹²,Liu Jun¹²

Affiliation:

1. Cheeloo College of Medicine Shandong University Jinan Shandong Province China

2. Department of Hepatobiliary Surgery and Center of Organ Transplantation, Shandong Provincial Hospital, Cheeloo College of Medicine Shandong University Jinan Shandong Province China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.26387

Reference38 articles.

1. Hepatocellular carcinoma: current management and recent advances;Lau WY;Hepatobiliary Pancreat Dis Int,2008

2. Hepatocellular carcinoma epidemiology;Bosetti C;Best Pract Res Clin Gastroenterol,2014

3. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria;Ravaioli M;Liver Transpl,2004

4. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches;Sapisochin G;Nat Rev Gastroenterol Hepatol,2017

5. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression;Vivarelli M;Liver Transpl,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the Boundaries for Liver Transplantation for Hepatocellular Carcinoma;Surgical Clinics of North America;2024-02

2. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma;Experimental & Molecular Medicine;2024-01-04

3. Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation;Hepatobiliary Surgery and Nutrition;2023-12

4. Modification of immunosuppressive regimen in case of malignancy in liver transplant recipients: Results of a French nationwide survey;Clinics and Research in Hepatology and Gastroenterology;2023-11

5. DRESS syndrome in a patient undergoing stem cell transplantation: Can sirolimus be involved?;Clinical Case Reports;2023-09